The Possible Role of Adipokines in HCV Associated Hepatocellular Carcinoma

Abstract

Background: Adipokines play an important role in the regulation of inflammation and tumor progression. Aim: Assessment of the possible role of adiponectin, leptin and visfatin in HCV associated hepatocellular carcinoma (HCC). Methods: patients were classified into 85 patients with HCV associated HCC, 100 patients with chronic hepatitis C viral (HCV) infection compared to 50 normal control (NC) subjects. All subjects included in the study were assessed for HCV infection by seropositive HCV antibodies, as well as HCV RNA by RT-PCR. Serum levels of adiponectin, leptin and visfatin were assessed using enzyme linked immunosorbent assay (ELISA). The data were correlated to the relevant clinic-pathological features of the patients, and the overall survival (OS) rate. Results: There was a significant difference in the serum levels of adiponectin and visfatin among HCC, HCV and NC groups (P<0.001). The serum levels of leptin and alpha fetoprotein (AFP) were significantly higher in HCC group (P<0.001). There was a significant association between the serum level of adiponectin and advanced Child class liver cirrhosis (P=0.03), as well as with poor performance status (ECOG, P=0.02). Serum leptin associated significantly with the number of lesions in the liver (P=0.006), visfatin associated with increased mortality rate (P<0.001). Adiponectin, leptin and visfatin associated significantly with liver cirrhosis in HCV patients (P<0.01). Leptin achieved the highest sensitivity (98.8%). visfatin achieved the highest specificity (100%) and PPV (100%) for detection of HCC. The combination of serum leptin and visfatin for the diagnosis of HCV associated HCC showed sensitivity, specificity, PPV, NPV and accuracy (100%, 96.6%, 93.4%, 100% and 97.4%; respectively). Conclusion: Adiponectin, leptin and visfatin have an important role(s) in the pathogenesis of HCV associated HCC.

The role of serum visfatin and vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis

“…We found that serum visfatin and vaspin levels were substantially higher in cirrhotic patients with HCC than those with liver cirrhosis and healthy controls. This is consistent with earlier studies that found significantly higher serum levels of visfatin [ 11 , 12 , 19 ] and vaspin [ 6 , 18 ] in HCC patients, and this could be linked to more advanced inflammation and higher HCC risk [ 2 ]. Ninomiya et al .…”

“…To date, few studies have been conducted to investigate the role of serum visfatin and vaspin in HCC patients with inconclusive results. Moreover, their relevance in the diagnosis of HCC is not fully elucidated [ 2 , 6 , 11 , 12 ]. Therefore, this study aimed to assess the potential role of serum visfatin and vaspin in HCV-cirrhotic patients with and without HCC on top and their possible association with tumour characteristics and liver dysfunction.…”

Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression

“…In patients with different stages of HCV infection, the plasma visfatin level was associated with the presence of HCC [108]. Consistent with this finding, the serum levels of visfatin differed significantly among HCC, HCV, and normal control groups, and the visfatin level was associated with liver cirrhosis in HCV-infected patients [109]. On the other hand, no correlation between visfatin and HCV genotype, viral load, or treatment response to IFN-based therapy has been shown [107].…”

“…Adiponectin, leptin, and visfatin have been found to be associated with liver cirrhosis in HCV-infected patients [109]. Sex was associated with leptin and adiponectin levels, and body mass index (BMI) was associated with leptin and PAI-1 levels in HCV-infected patients at baseline.…”

The Inter-Relation between Leptin Receptor (Q223R) Gene Polymorphism and the Risk of Egyptian Patients with HCC

“…Also, LEP stimulates pathophysiological conditions, such as hematopoiesis and polycystic ovarian syndrome. Despite the relationship of LEP to people with obesity, the changes of LEP and LEPRs might be related to the risk of many types of cancer (Wang et al, 2004, Swellam and Hamdy, 2012, El-Daly et al, 2020.…”